Biologics as novel therapeutics for the treatment of allergy: Challenges and opportunities.

Atanasio, Amanda; Orengo, Jamie M; Sleeman, Matthew A; Stahl, Neil

Atanasio, Amanda; Orengo, Jamie M; Sleeman, Matthew A; Stahl, Neil.

Afiliação

Atanasio A; Immunology and Inflammation, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.
Orengo JM; Immunology and Inflammation, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.
Sleeman MA; Immunology and Inflammation, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.
Stahl N; Research and Development, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.

Front Allergy ; 3: 1019255, 2022.

Article em En | MEDLINE | ID: mdl-36353195

Palavras-chave

IL-4/13; allergy; biologics; blocking igG antibodies; igE; immunotherapy; type 2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Front Allergy Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google